KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Resmed (RMD) Long-Term Debt Issuances (2016 - 2023)

Resmed (RMD) has disclosed Long-Term Debt Issuances for 13 consecutive years, with $105.0 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Long-Term Debt Issuances rose 110.0% year-over-year to $105.0 million, compared with a TTM value of $105.0 million through Jun 2024, down 90.19%, and an annual FY2024 reading of $105.0 million, down 90.19% over the prior year.
  • Long-Term Debt Issuances was $105.0 million for Q3 2023 at Resmed, down from $1.0 billion in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $1.0 billion in Q4 2022 and bottomed at $10.0 million in Q4 2021.
  • Average Long-Term Debt Issuances over 5 years is $226.5 million, with a median of $139.0 million recorded in 2021.
  • The sharpest move saw Long-Term Debt Issuances tumbled 90.27% in 2020, then surged 10100.0% in 2022.
  • Year by year, Long-Term Debt Issuances stood at $165.0 million in 2019, then crashed by 66.67% to $55.0 million in 2020, then plummeted by 81.82% to $10.0 million in 2021, then soared by 10100.0% to $1.0 billion in 2022, then tumbled by 89.71% to $105.0 million in 2023.
  • Business Quant data shows Long-Term Debt Issuances for RMD at $105.0 million in Q3 2023, $1.0 billion in Q4 2022, and $50.0 million in Q3 2022.